Lonza seeks deals as it exits health and ingredients to focus on contract development
By Isabel Demetz (Reuters) -Swiss contract drugmaker Lonza plans to simplify its structure and exit its capsules and health ...
The Globe and Mail1m
Stocks Slip Before the Open as Bond Yields Climb, U.S. PPI Data and ECB Decision in Focus
In corporate news, Lonza Group Ag (LONN.Z.IX) climbed over +6% following the Swiss contract drugmaker’s announcement of plans to exit its capsules and health ingredients business. The European ...